Description
BioS-2P is a groundbreaking synthetic peptide that functions as a dual agonist for both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This unique mechanism of action allows it to effectively regulate blood glucose levels by stimulating first- and second-phase insulin secretion while simultaneously reducing glucagon levels. Its structure, based on the native GIP sequence, is modified with a C20 fatty diacid moiety, which significantly extends its half-life and allows for once-weekly administration in clinical settings. Key research areas for Tirzepatide include the treatment of type 2 diabetes mellitus and chronic weight management in adults with obesity or overweight. Clinical trials have demonstrated its superior efficacy in both glycemic control and weight loss compared to selective GLP-1 receptor agonists. This product is intended for research purposes only and is not for human or veterinary use. All experiments should be conducted in a properly equipped laboratory by qualified professionals.
CAS: 2023788-19-2
PubChem CID: 156588324
Molecular Formula: C225H348N48O68
Molecular Weight: 4813.45 g/mol
Amino Acid Sequence: Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(γ-Glu-C20 diacid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser
Physical Form: Lyophilized Powder
Purity: ≥99%
Storage: -20°C, protected from light and moisture













